Matsui K - Search Results

1

Switching to antipsychotic monotherapy vs. staying on antipsychotic polypharmacy in schizophrenia: A systematic review and meta-analysis.

Matsui K, Tokumasu T, Takekita Y, Inada K, Kanazawa T, Kishimoto T, Takasu S, Tani H, Tarutani S, Hashimoto N, Yamada H, Yamanouchi Y, Takeuchi H. Matsui K, et al. Schizophr Res. 2019 Jul;209:50-57. doi: 10.1016/j.schres.2019.05.030. Epub 2019 Jun 8. Schizophr Res. 2019. PMID: 31182319

2

Effect of aripiprazole on non-24-hour sleep-wake rhythm disorder comorbid with major depressive disorder: a case report.

Matsui K, Takaesu Y, Inoue T, Inada K, Nishimura K. Matsui K, et al. Neuropsychiatr Dis Treat. 2017 May 19;13:1367-1371. doi: 10.2147/NDT.S136628. eCollection 2017. Neuropsychiatr Dis Treat. 2017. PMID: 28579782 Free PMC article.

3

Clozapine-induced agranulocytosis in Japan: Changes in leukocyte/neutrophil counts before and after discontinuation of clozapine.

Matsui K, Ishibashi M, Kawano M, Oshibuchi H, Ishigooka J, Nishimura K, Inada K. Matsui K, et al. Hum Psychopharmacol. 2020 Jul;35(4):e2739. doi: 10.1002/hup.2739. Epub 2020 May 18. Hum Psychopharmacol. 2020. PMID: 32420645

4

Clinical Factors Associated with New-Onset Glucose Intolerance among Patients with Schizophrenia during Clozapine Treatment: All-Case Surveillance in Japan.

Ishibashi M, Matsui K, Kawano M, Oshibuchi H, Ishigooka J, Nishimura K, Inada K. Ishibashi M, et al. Among authors: matsui k. Tohoku J Exp Med. 2020 Oct;252(2):177-183. doi: 10.1620/tjem.252.177. Tohoku J Exp Med. 2020. PMID: 33055431 Free article.

5

The efficacy of add-on ramelteon and subsequent dose reduction in benzodiazepine derivatives/Z-drugs for the treatment of sleep-related eating disorder and night eating syndrome: a retrospective analysis of consecutive patients.

Matsui K, Kuriyama K, Kobayashi M, Inada K, Nishimura K, Inoue Y. Matsui K, et al. J Clin Sleep Med. 2021 Jul 1;17(7):1475-1483. doi: 10.5664/jcsm.9236. J Clin Sleep Med. 2021. PMID: 33704048 Free PMC article.

6

Development and validation of the Benzodiazepine Hypnotics Withdrawal Symptom Scale (BHWSS) based on item response theory.

Narisawa H, Inoue Y, Kobayashi M, Okajima I, Kikuchi T, Kagimura T, Matsui K, Inada K, Mishima K. Narisawa H, et al. Among authors: matsui k. Psychiatry Res. 2021 Jun;300:113900. doi: 10.1016/j.psychres.2021.113900. Epub 2021 Mar 24. Psychiatry Res. 2021. PMID: 33812220

7

Prevalence of Circadian Rhythm Sleep-Wake Disorder in Outpatients with Schizophrenia and Its Association with Psychopathological Characteristics and Psychosocial Functioning.

Matsui K, Inada K, Kuriyama K, Yoshiike T, Nagao K, Oshibuchi H, Akaho R, Nishimura K. Matsui K, et al. J Clin Med. 2021 Apr 5;10(7):1513. doi: 10.3390/jcm10071513. J Clin Med. 2021. PMID: 33916411 Free PMC article.

8

Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia.

Aoki Y, Takaesu Y, Matsui K, Tokumasu T, Tani H, Takekita Y, Kanazawa T, Kishimoto T, Tarutani S, Hashimoto N, Takeuchi H, Mishima K, Inada K. Aoki Y, et al. Among authors: matsui k. Neuropsychopharmacol Rep. 2023 Sep;43(3):391-402. doi: 10.1002/npr2.12366. Epub 2023 Jul 14. Neuropsychopharmacol Rep. 2023. PMID: 37452456 Free PMC article.

9

Relapse of schizophrenia associated with comorbid delayed sleep-wake phase disorder but not with evening chronotype.

Matsui K, Kuriyama K, Yoshiike T, Kawamura A, Nagao K, Izuhara M, Hazumi M, Inada K, Nishimura K. Matsui K, et al. Schizophr Res. 2023 Nov;261:34-35. doi: 10.1016/j.schres.2023.09.009. Epub 2023 Sep 8. Schizophr Res. 2023. PMID: 37690169 No abstract available.

10

Effect of Yokukansan for the Treatment of Idiopathic Rapid Eye Movement Sleep Behavior Disorder: A Retrospective Analysis of Consecutive Patients.

Matsui K, Sasai-Sakuma T, Ishigooka J, Nishimura K, Inoue Y. Matsui K, et al. J Clin Sleep Med. 2019 Aug 15;15(8):1173-1178. doi: 10.5664/jcsm.7816. J Clin Sleep Med. 2019. PMID: 31482840 Free PMC article.

CONCLUSIONS: Considering the effectiveness of YKS and the low likelihood of adverse events, YKS should be considered as a potential treatment for patients with RBD. CITATION: Matsui K, Sasai-Sakuma T, Ishigooka J, Nishimura K, Inoue Y. Effect of yokukansan fo …

CONCLUSIONS: Considering the effectiveness of YKS and the low likelihood of adverse events, YKS should be considered as a potential treatmen …

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,670 results

Search Page

Filters